Brief: Compass Therapeutics Reports Q4 Net Loss Of $0.10 Per Share

Compass Therapeutics

15/03/2023 12:47

March 15 (Reuters) - Compass Therapeutics Inc.  CMPX.O :
    * COMPASS THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
    * ENDED 2022 WITH $187 MILLION IN CASH AND MARKETABLE
SECURITIES
PROVIDING CASH RUNWAY FOR COMPANY INTO 2026
    * QTRLY NET LOSS PER SHARE $0.10
    * Q3 EARNINGS PER SHARE VIEW $-0.11 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX4RKVHh 
Further company coverage:  CMPX.O 

 ((Reuters.Briefs@thomsonreuters.com;))